Crossref
Mechanism of miR-503-5p on cardiac hemangioma and clinical validation: Am J Cancer Res. 2024; 14(11): 5304-5320
American Journal of Cancer Research · 2026 · 16 (10) · 4679-4682
DOI: 10.62347/jcct4943 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Cancer Research, 2026. Verfasst von Kai Lu und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lu, K., Zhang, W., Tang, X., Yin, R., Wang, T., Wei, X., & Pan, C. (2026). Mechanism of miR-503-5p on cardiac hemangioma and clinical validation: Am J Cancer Res. 2024; 14(11): 5304-5320. American Journal of Cancer Research, 16(10), 4679-4682. https://doi.org/10.62347/jcct4943
Vancouver
Lu K, Zhang W, Tang X, Yin R, Wang T, Wei X, et al. Mechanism of miR-503-5p on cardiac hemangioma and clinical validation: Am J Cancer Res. 2024; 14(11): 5304-5320. American Journal of Cancer Research. 2026;16(10):4679-4682. doi:10.62347/jcct4943
BibTeX
@article{Lu2026,
author = {Lu, Kai and Zhang, Wanchao and Tang, Xiaoqiang and Yin, Ruohan and Wang, Tao and Wei, Xiaoyu and Pan, Changjie},
title = {Mechanism of miR-503-5p on cardiac hemangioma and clinical validation: Am J Cancer Res. 2024; 14(11): 5304-5320},
journal = {American Journal of Cancer Research},
year = {2026},
volume = {16},
number = {10},
pages = {4679--4682},
doi = {10.62347/jcct4943}
}
EUVIMED